Pimobendan 74150-27-9 Metabolism PDE inhibitor
Totogi:T/T, L/C
Puna'oa:Saina
Taulaga Va'a:Beijing/Shanghai/Hangzhou
Poloaiga (MOQ):1g
Taimi muamua:3 aso faigaluega
Gaosi gaosiga:1kg/masina
Tulaga teuina:Teu i totonu o se nofoaga malulu, matutu, potu vevela.
Mea fa'apipi'i:fagu, fagu
Tele le afifi:1g/ fagu, 5/ fagu, 10g/ fagu, 50g/fagu, 500g/fagu
Fa'amatalaga saogalemu:UN 2811 6.1/PG 3

Folasaga
Pimobendan, o se vaila'au fa'afoma'i.O se faʻamaʻi maʻaleʻale calcium ma se inhibitor filifilia o le phosphodiesterase 3 (PDE3) faʻatasi ai ma aʻafiaga lelei inotropic ma vasodilator.
O le Pimobendan e fa'aaogaina i le puleaina o le faaletonu o le fatu i taifau, e masani ona mafua mai i le myxomatous mitral valve maʻi (lea na taʻua muamua o le endocardiosis), poʻo le cardiomyopathy dilated.O suʻesuʻega ua faʻaalia e pei o le monotherapy, o le pimobendan e faʻateleina ai le taimi e ola ai ma faʻaleleia le lelei o le olaga i tagata gasegase e maua i le fatu faʻaletonu lona lua i le faʻamaʻi valve mitral pe a faʻatusatusa i le benazepril, o le ACE inhibitor.
Fa'amatalaga (USP43)
Aitema | Fa'amatalaga |
Fa'aaliga | Pa'epa'e pe lanu samasama pa'epa'e, hygroscopic |
Mp | E tusa o le 242℃ |
Solubility | E le mafai ona solu ile vai, solu fua ile dimethylformamide, solute laititi ile acetone ma le methanil. |
Fa'ailoaga | Infrared absorption spectrophotometry, Fa'atusatusaga pimobendan CRS. |
O le taimi fa'atumauina o le tumutumu tele o le Sample solution e fetaui ma le fa'ata'ita'iga o fa'atauga masani, e pei ona maua i le su'ega Organic Impurities. | |
Metala mamafa | ≤10ppm |
Fa'amamafa | P90 ≤ 25μm |
Lapopo'a o vaega | 20-80 mata |
Solivai totoe | ≤ 500ppm |
Vai | ≤ 1.0% |
Su'ega | 98.0%~102.0% |
Lefulefu sulphated | ≤ 0.10% |
Mea fa'atatau (HPLC) | |
le mama A | ≤ 0.10% |
le mama B | ≤ 0.10% |
So'o se isi mea leaga | ≤ 0.10% |
Le mama atoatoa | ≤ 0.20% |